SCHEMBL6062437

SCHEMBL6062437

[CH2][C@H](C(=O)N(CCCC)C(O)c1nc2ccccc2o1)S(=O)(=O)Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PTPN2 P17706 4/20 0.42
PTPN1 P18031 4/20 0.42
HSF1 Q00613 2/20 0.40
ALDH1A1 P00352 3/20 0.37
MAPT P10636 2/20 0.37
KMT2A Q03164 2/20 0.37
HSD17B10 Q99714 2/20 0.37
F2 P00734 1/20 0.37
LMNA P02545 1/20 0.37
MIF P14174 1/20 0.37
PPARA Q07869 8/20 0.37
PPARG P37231 6/20 0.37
PPARD Q03181 5/20 0.37
ATM Q13315 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
TP53 P04637 1/20 0.36
HSP90AA1 P07900 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6632355 0.81 PTPN1 (0.40) PTPN2PTPN1ALDH1A1MAPTKMT2A
SCHEMBL6628452 0.81 PTPN1 (0.40) PTPN2PTPN1ALDH1A1MAPTKMT2A
SCHEMBL6628447 0.78 MAPT (0.42) PTPN2PTPN1ALDH1A1MAPTKMT2A
SCHEMBL6061710 0.78 MAPT (0.42) PTPN2PTPN1ALDH1A1MAPTKMT2A
SCHEMBL6048156 0.72 HSF1 (0.39) HSF1ALDH1A1MAPTKMT2AHSD17B10
SCHEMBL6630261 0.71 ACACB (0.38) PTPN2PTPN1
SCHEMBL10480340 0.71 ALDH1A1 (0.48) PTPN2PTPN1ALDH1A1LMNATDP1
SCHEMBL6630253 0.69 ACACB (0.36) PTPN2PTPN1PPARAPPARGPPARD
SCHEMBL6628528 0.68 CTSK (0.37) PTPN2PTPN1HSF1ALDH1A1MAPT
SCHEMBL6628517 0.68 CTSK (0.46) PTPN2PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1694357-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2006-08-30 EP disclosed
WO-2005058348-A1 USE OF CATHEPSIN S INHIBITORS FOR TREATING AN IMMUNE RESPONSE CAUSED BY ADMINISTRATION OF A SMALL MOLECULE THERAPEUTIC OR BIOLOGIC AXYS PHARMACEUTICALS, INC. (US) 2005-06-30 WO disclosed